Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Carl Zeiss Meditec AG (1AFX)
Market Open
15 Jun, 07:49
XMIL
All
(12)
DE
(6)
AT
(1)
CH
(1)
IT
(1)
GB
(2)
US
(1)
XETRA
Primary
LSE
XDUS
XSTU
XMUN
XWBO
XFRA
XHAN
OTC PINK
XMIL
CBOE
SIX
25.
34
+0.3
+1.1981%
3.75B
Market Cap
-
P/E Ratio
4.4%
Div Yield
1,098
Volume
-
Eps
25.04
Previous Close
Watching
Watch
Add Transaction
Day Range
25.34
25.42
Year Range
22.88
61.25
Want to track
1AFX
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Carl Zeiss Meditec AG (1AFX) Statistics
Valuation metrics
Market Cap
3.75B
Enterprise value
2.65B
Trailing P/E (ttm)
16.15
Forward P/E
-
PEG ratio
-
Price/Sales (ttm)
1.03
Price/Book (mrq)
1.08
Enterprise Value/Revenue
1.2
Enterprise Value/EBITDA
10.67
Overview
Shares outstanding
87.54M
Float
32.35M
Shares short
-
% Held by insiders
0.59%
% Held by institutions
0.23%
Average volume (10 days)
220
Average volume (90 days)
670
Price summary
52-Week low
22.88
52-Week high
61.25
Beta
1.34
50-Day moving average
25.54
200-Day moving average
38.97
Dividends and splits
Forward annual dividend rate
2.2
Forward annual dividend yield
0.0846%
Trailing annual dividend rate
0.55
Trailing annual dividend yield
0.0212%
5-Year annual dividend yield
-
Payout ratio
0.37
Dividend Date
3 Apr 2026
Ex-Dividend Date
27 Mar 2026
Last split factor
894:653
Last split Date
24 Oct 2006
Financials
Fiscal year
Fiscal year ends
30 Sep 2025
Most recent quarter (mrq)
30 Sep 2025
Profitability
Profit margin
0.05%
Operating margin
-0%
Operational effectiveness
Return on assets
0.04%
Return on equity
0.06%
Income Statement
Revenue (ttm)
2.2B
Revenue per share (ttm)
25.59
Quarterly revenue growth (yoy)
-0.05%
Gross profit (ttm)
1.15B
EBITDA
220.56M
Net income to common (ttm)
120.61M
Diluted EPS (ttm)
1.61
Quarterly earnings growth (yoy)
0.08%
Balance Sheet
Total cash (mrq)
27.27M
Total cash per share (mrq)
0.33
Total debt (mrq)
534.94M
Total Debt/Equity (mrq)
25.14
Current ratio (mrq)
2.34%
Book value per share (mrq)
24.18
Cash Flow
Cash flow statement
79.42M
Levered free cash flow (LFCF)
141.21M